-
Entity
-
Individual
-
Location
-
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, Massachusetts
-
Summary
-
The estimated net worth of Ronald C. Renaud JR is at least $22.3 M dollars as of January 23, 2024. Ronald C. Renaud JR is the President & CEO, Director of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. (CERE) stock worth about $22.3 M. Ronald C. Renaud JR is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3 K.